Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;6(5):643-657.
doi: 10.1038/s41564-021-00875-2. Epub 2021 Mar 22.

Candida pathogens induce protective mitochondria-associated type I interferon signalling and a damage-driven response in vaginal epithelial cells

Affiliations

Candida pathogens induce protective mitochondria-associated type I interferon signalling and a damage-driven response in vaginal epithelial cells

Marina Pekmezovic et al. Nat Microbiol. 2021 May.

Abstract

Vaginal candidiasis is an extremely common disease predominantly caused by four phylogenetically diverse species: Candida albicans; Candida glabrata; Candida parapsilosis; and Candida tropicalis. Using a time course infection model of vaginal epithelial cells and dual RNA sequencing, we show that these species exhibit distinct pathogenicity patterns, which are defined by highly species-specific transcriptional profiles during infection of vaginal epithelial cells. In contrast, host cells exhibit a homogeneous response to all species at the early stages of infection, which is characterized by sublethal mitochondrial signalling inducing a protective type I interferon response. At the later stages, the transcriptional response of the host diverges in a species-dependent manner. This divergence is primarily driven by the extent of epithelial damage elicited by species-specific mechanisms, such as secretion of the toxin candidalysin by C. albicans. Our results uncover a dynamic, biphasic response of vaginal epithelial cells to Candida species, which is characterized by protective mitochondria-associated type I interferon signalling and a species-specific damage-driven response.

PubMed Disclaimer

References

    1. Mårdh, P.-A. et al. Facts and myths on recurrent vulvovaginal candidosis: a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy. Int. J. STD AIDS 13, 522–539 (2002). - PubMed - DOI
    1. Fidel, P. L.Jr et al. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect. Immun. 72, 2939–2946 (2004). - PubMed - PMC - DOI
    1. Rosati, D., Bruno, M., Jaeger, M., Ten Oever, J. & Netea, M. G. Recurrent vulvovaginal candidiasis: an immunological perspective. Microorganisms 8, 144 (2020). - PMC - DOI
    1. Yano, J. et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health 19, 48 (2019). - PubMed - PMC - DOI
    1. Makanjuola, O., Bongomin, F. & Fayemiwo, S. A. An update on the roles of non-albicans Candida species in vulvovaginitis. J. Fungi (Basel) 4, 121 (2018). - DOI

Publication types

MeSH terms

LinkOut - more resources